Before revision: Leadership BioMotiv is managed by an executive team, including: Ron Harrington, Chairman of the Board of Managers Baiju R. Shah, CEO Ted Torphy, PhD, Chief Scientific Officer David C. U'Prichard, PhD, Chairman of the Advisory Board Ron Harrington, BioMotiv's Board of Managers Chairman and The Harrington Project's lead visionary, led Edgepark Medical Supplies and after growing the business successfully, sold the company in 2011 to Goldman Sachs and Clayton, Dubilier & Rice (which renamed the company AssuraMed and sold it again in 2014 to Cardinal Health, Inc.).
After revision: Leadership Ron Harrington, BioMotiv's Board of Managers Chairman and The Harrington Project's lead visionary, led Edgepark Medical Supplies and after growing the business successfully, sold the company in 2011 to Goldman Sachs and Clayton, Dubilier & Rice (which renamed the company AssuraMed and sold it again in 2014 to Cardinal Health, Inc.).